Wageningen University

KeyGene, Chiquita, and Wageningen University develop banana plant resistant to Fusarium TR4 and black sigatoka, named Yelloway One, combining traditional and modern techniques for field trials in the Philippines and Indonesia. The Bezos Centre for Sustainable Protein opens at the National University of Singapore with a $30 million grant, focusing on microalgae, biomass fermentation, and cultivated meat research.

Critics warn carbon credit system has loopholes, risks like human rights abuses and greenwashing. Aarti Gupta warns Article 6 could prioritize carbon trading over direct climate finance. Martin Hession defends safeguards against greenwashing. Trishant Dev highlights issues in endorsement process. COP29 faces pressure to address climate integrity and community protection.

Lixte Biotechnology Holdings, Inc. schedules its 2024 Annual Meeting of Stockholders for December 19, 2024, to vote on the election of five director nominees, ratification of Weinberg & Company, P.A. as the independent registered public accounting firm, and approval of executive officer compensation. The meeting will be virtual, accessible via a live webcast.

Self-amplifying mRNA (samRNA) vaccines face scientific and regulatory challenges, but experts believe they will eventually enter the market, especially for infectious diseases and cancer. Despite initial setbacks, Gennova Biopharmaceuticals' Gemcovac and Arcturus Therapeutics' Kostaive have gained approvals in India and Japan, respectively. The success of Kostaive is attributed to strategic timing and unique trial conditions. While samRNA therapeutics offer potential benefits over standard mRNA vaccines, technical hurdles and safety concerns remain, affecting their widespread adoption.